Literature DB >> 20524146

Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species.

Jiazhong Sun1, Yancheng Xu, Suxin Sun, Yanlei Sun, Xiang Wang.   

Abstract

Proliferation of human retinal endothelial cells (HRECs) is an important event in the development of diabetic retinopathy. Glucose fluctuations are strong predictor of diabetic vascular complications. In this study we have investigated the effect of intermittent high glucose on proliferation and expression of vascular endothelial growth factor (VEGF) in HRECs. The possible involvement of mitochondrial reactive oxygen species (ROS) was assessed. HRECs were incubated for 72 h in media containing different glucose concentrations: 5, 25, 5 mmol/l alternating with 25 mmol/l glucose, with or without Mn(III)tetrakis(4-benzoic acid) porphyrin chloride (MnTBAP) and thenoyltri-fluoroacetone (TTFA). The cell proliferation, VEGF expression, mitochondrial ROS, nitrotyrosine and 8-hydroxydeoxyguanosine (8-OHdG) were measured. In cultured HRECs, treatment with constant or intermittent high glucose significantly increased [(3)H]thymidine incorporation in a time-dependent manner. Treatment with constant high glucose for 48 h resulted in significant increases in [(3)H]thymidine incorporation, mRNA and protein levels of VEGF compared with HRECs treated with the normal glucose, which were markedly enhanced in cells exposed to intermittent high glucose. The levels of mitochondrial ROS, nitrotyrosine and 8-OhdG were significantly elevated under both intermittent and constant high glucose conditions, the effect being greater under intermittent high glucose. In addition, the antioxidants MnTBAP or TTFA can effectively prevent cell proliferation and overexpression of VEGF, as well as overproduction of mitochondrial ROS, nitrotyrosine and 8-OhdG in HRECs induced by constant or intermittent high glucose. Intermittent high glucose enhances cell proliferation and overexpression of VEGF through reactive oxygen species (ROS) overproduction at the mitochondrial transport chain level in HRECs, indicating that glycemic variability have important pathological effects on the development of diabetic retinopathy dependent of mitochondrial ROS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524146     DOI: 10.1007/s11010-010-0495-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients.

Authors:  José A Gimeno-Orna; Francisco J Castro-Alonso; Beatriz Boned-Juliani; Luis M Lou-Arnal
Journal:  J Diabetes Complications       Date:  2003 Mar-Apr       Impact factor: 2.852

3.  Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.

Authors:  I G Obrosova; A G Minchenko; V Marinescu; L Fathallah; A Kennedy; C M Stockert; R N Frank; M J Stevens
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

Review 4.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.

Authors:  R A Kowluru; R L Engerman; T S Kern
Journal:  Curr Eye Res       Date:  2000-10       Impact factor: 2.424

Review 6.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

7.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

Review 8.  Microvascular complications of impaired glucose tolerance.

Authors:  J Robinson Singleton; A Gordon Smith; James W Russell; Eva L Feldman
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

Review 9.  Hyperglycemia and microvascular and macrovascular disease in diabetes.

Authors:  R Klein
Journal:  Diabetes Care       Date:  1995-02       Impact factor: 19.112

10.  A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2008-07-23       Impact factor: 17.152

View more
  31 in total

1.  Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.

Authors:  Yuan Zhu; Xiao-Ling Zhang; Bo-Feng Zhu; Yan-Ning Ding
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

Review 2.  Proteinaceous cysteine protease inhibitors.

Authors:  G Dubin
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

Review 3.  ROS signaling and redox biology in endothelial cells.

Authors:  Emiliano Panieri; Massimo M Santoro
Journal:  Cell Mol Life Sci       Date:  2015-05-14       Impact factor: 9.261

4.  GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data.

Authors:  Dorota Czerwoniuk; Wojciech Fendler; Lukasz Walenciak; Wojciech Mlynarski
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

5.  Activation of retinal Müller cells in response to glucose variability.

Authors:  Fabiana Picconi; Mariacristina Parravano; Francesca Sciarretta; Chiara Fulci; Michela Nali; Simona Frontoni; Monica Varano; Anna Maria Caccuri
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

6.  Effect of Glucose on Retinal Endothelial Cell Viability and VEGF Secretion.

Authors:  Brandi S Betts-Obregon; Sandeep Vellanki; Jessica Buikema; Andrew T Tsin; Keli Wright
Journal:  HSOA J Cell Biol Cell Metabol       Date:  2016-03-25

7.  The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes.

Authors:  Robert A Vigersky; John Shin; Boyi Jiang; Thorsten Siegmund; Chantal McMahon; Andreas Thomas
Journal:  J Diabetes Sci Technol       Date:  2017-07-27

8.  Identifying disrupted pathways by tracking altered modules in type 2 DM-related heart failure.

Authors:  H Liu; X Han; Y Li
Journal:  Herz       Date:  2016-06-30       Impact factor: 1.443

Review 9.  Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature.

Authors:  Sara J Salkind; Robert Huizenga; Stephanie J Fonda; M Susan Walker; Robert A Vigersky
Journal:  J Diabetes Sci Technol       Date:  2014-05-29

Review 10.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.